Cavernous Sinus Thrombosis: Symptoms and Emergency Care

Cavernous sinus thrombosis is a rare but life-threatening condition in which a thrombus forms within the cavernous venous sinus. It is most often septic in nature as a complication of infections of the sinuses, facial skin, orbit, and oral cavity, and less commonly aseptic due to systemic thrombophilia or trauma. Rapidly progressing ophthalmologic and neurologic symptoms combined with fever require urgent diagnosis and initiation of antibiotic therapy and anticoagulation, unless contraindicated. [1]

The key to recognition is a combination of headache, fever, proptosis, chemosis, ophthalmoplegia, and cranial nerve involvement of the third, fourth, first, and second branches of the trigeminal nerve, as well as the sixth nerve. Bilaterality and rapid reversal of the process due to intersinus communication are common. Without treatment, the condition leads to blindness, stroke, meningitis, sepsis, and death. [2]

Epidemiology

Cavernous sinus thrombosis accounts for approximately 1-4 percent of all cerebral venous sinus thromboses. Given the overall incidence of cerebral venous thrombosis of approximately 2-4 cases per million population per year, the estimated incidence of cavernous sinus thrombosis is approximately 0.2-1.6 per 100,000 per year. The disease occurs in people of any gender and age, although it may be somewhat more common in men in septic series. [3]

In developed countries, bacterial septic cases predominate as complications of acute sinusitis and periorbital infections. In childhood, the relative frequency is higher, which is associated with the high incidence of sinusitis and the peculiarities of venous connections. A growing contribution of methicillin-resistant Staphylococcus aureus has been reported. [4]

Reasons

Most cases are caused by bacterial infections. Staphylococci account for about two-thirds of the cases, followed by streptococci and pneumococci, as well as gram-negative and anaerobic bacteria, especially in cases of odontogenic lesions or necrotic sinusitis. In immunocompromised patients, fungal etiologies are possible, primarily aspergillosis and mucormycosis. [5]

Aseptic thrombosis occurs in systemic thrombophilia, malignant tumors, dehydration, nephrotic syndrome, sickle cell disease, and after trauma or neurosurgical interventions. These mechanisms are important in the absence of an obvious infectious focus and require different management tactics. [6]

Risk factors

The leading risk factors are acute bacterial rhinosinusitis, nasolabial fold furuncles, periorbital cellulitis, and orbital abscesses. Uncontrolled diabetes mellitus, immunosuppression, glucocorticosteroid use, and malignant diseases also play a role. Thrombophilias, including the factor V Leiden mutation, the prothrombin G20210A mutation, antithrombin, protein C, and protein S deficiencies, elevated factor VIII, and antiphospholipid syndrome, increase the risk of thrombosis. [7]

In women, the risk increases during pregnancy, the postpartum period, and while taking oral contraceptives. In children and adolescents, frequent odontogenic and otogenic infections are an additional factor. [8]

Pathogenesis

Infection spreads from the sinuses and soft tissues of the face through the orbital venous network and pterygopalatine plexus into the cavernous sinus, where it causes endophlebitis, a local thrombotic cascade, and venous congestion. Dilation and thrombosis of the superior ophthalmic vein are typical indirect signs of outflow obstruction. Inflammation and edema lead to compression of the cranial nerves running within the sinus walls and lumen, which determines the characteristic ophthalmoplegia. [9]

The proximity of the internal carotid artery explains potential ischemic complications, and the connections between the right and left sinuses account for the tendency for bilateral involvement. Venous hypertension in the orbit causes proptosis, chemosis, and eyelid edema. [10]

Symptoms

The onset is usually acute or subacute: intense headache, fever, facial and orbital pain, tenderness to palpation, and ophthalmological signs quickly follow—proptosis, chemosis, decreased ocular motility, double vision, and decreased sensitivity in the area of the first and second branches of the trigeminal nerve. The earliest and most common focal sign is paresis of the sixth cranial nerve with limited abduction of the eyeball. [11]

Warning signs include bilateral ocular involvement, increasing ophthalmoplegia, decreased visual acuity, papilloedema, and impaired consciousness. These signs reflect the progression of thrombosis and the spread of infection into the cranial cavity and require immediate escalation of treatment. [12]

Forms and stages

Septic cavernous sinus thrombosis is the most common and aseptic variant, occurring in the setting of thrombophilia or trauma. The course may be unilateral, with rapid transition to the opposite side due to intersinus communication. Based on the course of the disease, an acute stage with pronounced inflammatory symptoms and a complication stage with neurological deficits and intracranial infections are distinguished. [13]

The phenotype “cavernous sinus syndrome” unites various causes of damage to this area, therefore, when diagnosing, it is important to separate thrombosis from tumors, inflammatory and vascular processes, since treatment tactics differ sharply. [14]

Complications and consequences

Major complications include purulent meningitis, brain abscess, subdural empyema, ischemic stroke due to compression or thrombosis of the internal carotid artery branches, blindness due to optic nerve damage and macular ischemia, and sepsis. Even with treatment, some patients experience persistent cranial nerve palsy and visual impairment. [15]

Superior ophthalmic vein involvement and thrombosis increase venous congestion and the risk of irreversible vision loss. Bilateral involvement is associated with a poorer prognosis and a higher incidence of intracranial complications. [16]

Diagnostics

Magnetic resonance imaging of the brain with contrast and venography or computed tomography with contrast venography is urgently indicated. Magnetic resonance imaging is superior to computed tomography in detecting intracranial complications and better visualizes sinus walls, contrast filling, and thrombus. An indirect sign is dilation and thrombosis of the superior ophthalmic vein. [17]

Laboratory diagnostics include a complete blood count, C-reactive protein, blood cultures before starting antibiotics, and, if necessary, nasal and paranasal sinus swabs. If intracranial infection is suspected, a lumbar puncture after ruling out mass effect is necessary. Etiologic verification allows for narrowing empirical therapy. [18]

Table 1. Key visualization methods and landmarks

Method	What are we looking for?	Comments
Magnetic resonance imaging of the brain with contrast and venography	Contrast filling, filling defect, sinus wall thickening, asymmetry, dilation of the superior ophthalmic vein	The most accurate method for intracranial complications
Computed tomography with contrast venography	Filling defect, wall thickening, indirect signs of orbital congestion	Quick access in an emergency
Magnetic resonance imaging of the orbits	Dilation and thrombus of the superior ophthalmic vein, edema of the retrobulbar tissue	Useful for severe ophthalmology

Table 2. Signs of damage on magnetic resonance imaging and computed tomography

Sign	Meaning
Cavernous sinus filling defect	A direct sign of thrombosis
Convex bulging of the sinus wall	Inflammation and swelling of the wall
Narrowing of the flow in the internal carotid artery in the cavernous segment	Compression, risk of ischemia
Dilation of the superior ophthalmic vein, possible thrombosis	Indirect sign of venous hypertension of the orbit

Differential diagnosis

Cavernous sinus thrombosis must be distinguished from orbital cellulitis, which often mimics ophthalmologic findings. However, thrombosis is more often characterized by bilaterality, pronounced neurological symptoms, and signs of intracranial involvement. It is also differentiated from carotid-cavernous fistula, Tolosa-Hunt syndrome, tumors, and inflammatory granulomatous pathology. [19]

Treatment

Immediate empirical antibacterial therapy

Treatment begins immediately after blood cultures are taken. An intravenous combination regimen covering methicillin-resistant Staphylococcus aureus, aerobic Gram-negative bacteria, and anaerobes is recommended: vancomycin plus ceftriaxone or cefepime plus metronidazole. In cases of odontogenic lesions and suspected anaerobes, metronidazole is mandatory. Duration of therapy is usually 3-4 weeks, with subsequent de-escalation based on culture results. [20]

Anticoagulation

Most current guidelines on cerebral venous thrombosis support heparin anticoagulation in the acute phase to prevent thrombotic progression and recurrence, even in the presence of venous intracranial hemorrhage due to venous hypertension. For septic cavernous sinus thrombosis, the evidence base is limited, but many experts and reviews recommend considering heparin in the absence of contraindications and during comprehensive antibacterial therapy. Low-molecular-weight or unfractionated heparin is preferred, followed by a switch to vitamin K antagonists. [21]

Surgery of the lesion and otolaryngological tactics

In parallel with systemic therapy, treatment of the primary lesion is considered: endoscopic surgery of the paranasal sinuses for complicated sinusitis, drainage of orbital and subperiosteal abscesses, and treatment of odontogenic lesions. The decision is made interdisciplinary, involving an otolaryngologist and ophthalmologist. [22]

The role of glucocorticosteroids and antifungal therapy

Routine glucocorticosteroid use is not recommended for cerebral venous thrombosis due to the lack of survival benefit and associated risks. Exceptions are possible in cases of severe orbital edema, based on vital indications and individual decision-making. Antifungal agents are prescribed only if a fungal etiology is confirmed or highly probable. [23]

Table 3. Empirical intravenous regimens at the start of treatment

Clinical situation	Basic scheme	Alternatives and additions
Suspected staphylococcal sinusogenic process	Vancomycin plus ceftriaxone	Vancomycin plus cefepime; add metronidazole for odontogenic lesions
High risk of anaerobes	Previous regimen plus metronidazole	Consider piperacillin-tazobactam as the only component
Confirmed methicillin-susceptible staphylococcus	Nafcillin or oxacillin plus a third-generation cephalosporin	De-escalation by sensitivity, duration up to 4 weeks

Table 4. Anticoagulation for venous sinus thrombosis: what is used in practice

Stage	Preparation	Notes
Acute period	Low molecular weight heparin or unfractionated heparin	Shown by most guidelines on cerebral venous thrombosis, in case of septic process the solution is individualized
Transition period	Vitamin K antagonists	The evidence base is better than for direct oral anticoagulants in the context of cerebral venous thrombosis
Direct oral anticoagulants	Considered in separate observational studies	Requires caution and is not standard for septic cavernous sinus thrombosis

Table 5. Indications for consultations and interventions of related specialists

Specialist	When to attract	Target
Otorhinolaryngologist	Complicated sinusitis, the need for endoscopic sinus sanitation	Elimination of the source of infection
Ophthalmologist	Decreased vision, severe proptosis, suspected retrobulbar abscess	Decision on drainage, visual function monitoring
Neurosurgeon	Suspected intracranial abscess, subdural empyema, unstable condition	Drainage, decompression as indicated
Infectious disease specialist	All septic cases	Escalation and de-escalation of antibacterial therapy

Table 6. Monitoring and control of therapy effectiveness

What to control	How often	What are we focusing on?
Clinical presentation and neurological status	Every day in the hospital	Regression of ophthalmoplegia, proptosis, temperature
Laboratory markers	After 48-72 hours and then according to indications	Reduction of C-reactive protein, normalization of leukocytosis
Control visualization	According to the clinic, usually within 5-7 days or if the condition worsens	Stabilization or regression of thrombosis and orbital signs

Prevention

Primary prevention involves prompt treatment of acute respiratory and odontogenic infections, especially acute bacterial rhinosinusitis, and early referral to an otolaryngologist if signs of complications arise. Oral hygiene, treatment of caries and abscesses, and caution when manipulating the nasopharynx and paranasal sinuses are important. [24]

Secondary prevention aims to identify and correct thrombophilia after the acute phase, particularly in patients with recurrent thrombosis and a family history. The decision to test for thrombophilia is made on an individual basis, taking into account the recommendations of hematological societies. Glycemic control in patients with diabetes mellitus and correction of immunodeficiency factors reduce the risk of severe septicemia. [25]

Forecast

Even with timely treatment, the risk of persistent neurological deficits, primarily oculomotor nerve palsy and visual impairment, remains. Full recovery is achieved in approximately half of patients, emphasizing the need for early recognition and aggressive multidisciplinary treatment. [26]

Delayed antibacterial therapy, bilateral involvement, and the presence of intracranial complications are associated with worse outcomes. The use of anticoagulation within the framework of modern approaches to cerebral venous thrombosis can improve recanalization and prevent progression, but in septic cavernous sinus thrombosis, the decision is always individualized. [27]

FAQ

• What antibiotics are prescribed in the first 24 hours?

Vancomycin plus ceftriaxone or vancomycin plus cefepime with the addition of metronidazole are most commonly started for odontogenic lesions. Duration is usually 3-4 weeks with de-escalation based on culture data. [28]

• Do all patients need anticoagulation?

Guidelines for cerebral venous thrombosis support heparin in the acute phase. For septic cavernous sinus thrombosis, evidence is less robust, but many experts recommend considering heparin in the absence of contraindications and with mandatory antibacterial therapy. [29]

• Which tests will confirm the diagnosis fastest?

Magnetic resonance imaging of the brain with contrast and venography is the method of choice. Computed tomography with contrast venography is applicable when access to magnetic resonance imaging is limited. Dilation of the superior ophthalmic vein is an important indirect sign. [30]

• How is cavernous sinus thrombosis different from orbital cellulitis?

In thrombosis, bilaterality, rapid involvement of multiple cranial nerves, papilloedema, and signs of intracranial infection are most often observed. Visualization of the venous sinuses and superior ophthalmic vein helps confirm the diagnosis. [31]

• When is surgery needed?

Primary lesion sanitation is indicated for complicated sinusitis, orbital or subperiosteal abscesses, and odontogenic infections. The decision is made jointly by an otolaryngologist, ophthalmologist, neurosurgeon, and infectious disease specialist. [32]